Loading
A phase 2 trial of nab-paclitaxel, carboplatin and capecitabine in triple-negative breast cancer, run by Hebei Medical University Fourth Hospital, now recruiting.
Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer is a phase 2, randomised interventional study registered as NCT04159142 by Hebei Medical University Fourth Hospital, with a registry enrolment figure of 414 participants, started 2019-11-20 and due to reach its primary completion in 2026-06-20. Interventions recorded: Nab-paclitaxel + Carboplatin; Nab-paclitaxel + Capecitabine. Conditions listed: Triple Negative Breast Cancer; Nab-paclitaxel. Triple-negative eligibility wording from the registry: "Histologically confirmed triple negative breast cancer;". Sites: China. No results are recorded here; the registry entry is the source.
Shares Nab-paclitaxel, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Carboplatin and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Carboplatin and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Carboplatin and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Carboplatin and the tag tnbc-deep-dive.
Shares Capecitabine, Metastatic triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents and the tag tnbc-deep-dive.
Shares Nab-paclitaxel, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Platinum agents, Carboplatin and the tag tnbc-deep-dive.